The associations of the assessed biomarkers with OS and PFS remained significant after adjusting for risk factors, which may affect survival of tumor patients (age, gender, biometric parameters, levels of established tumor markers CA 19–9 and CEA, presence of metastases). Here, CEACAM5 is linked to neoplasm.